SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-15-002741
Filing Date
2015-05-14
Accepted
2015-05-14 16:51:50
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 258356
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4260
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2982
  Complete submission text file 0001062993-15-002741.txt   4886992

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20150331.xml EX-101.INS 374367
5 XBRL SCHEMA FILE avxl-20150331.xsd EX-101.SCH 145420
6 XBRL CALCULATION FILE avxl-20150331_cal.xml EX-101.CAL 30434
7 XBRL DEFINITION FILE avxl-20150331_def.xml EX-101.DEF 423887
8 XBRL LABEL FILE avxl-20150331_lab.xml EX-101.LAB 929605
9 XBRL PRESENTATION FILE avxl-20150331_pre.xml EX-101.PRE 465963
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51652 | Film No.: 15863660
SIC: 8731 Services-Commercial Physical & Biological Research